Hecht M, Gaipl U, Fietkau R (2018)
Publication Type: Journal article
Publication year: 2018
Book Volume: 194
Pages Range: 269-271
Journal Issue: 3
DOI: 10.1007/s00066-017-1253-3
APA:
Hecht, M., Gaipl, U., & Fietkau, R. (2018). Durvalumab improves prognosis of stage III non-small-cell lung cancer after definitive chemoradiotherapy. Strahlentherapie und Onkologie, 194(3), 269-271. https://doi.org/10.1007/s00066-017-1253-3
MLA:
Hecht, Markus, Udo Gaipl, and Rainer Fietkau. "Durvalumab improves prognosis of stage III non-small-cell lung cancer after definitive chemoradiotherapy." Strahlentherapie und Onkologie 194.3 (2018): 269-271.
BibTeX: Download